3.0(top 20%)
2-year impact
3.2(top 20%)
3-year impact
3.2(top 10%)
5-year impact
3.7(top 10%)
10-year impact
4.8K(top 5%)
PR articles
117.8K(top 5%)
PR citations
120(top 5%)
PR h-index
134(top 5%)
h-index
3.5(top 20%)
extended IF
2.8(top 20%)
2-YI (article-only)
5.4(top 50%)
2-YI (review-only)
4.2(top 10%)
2-YI (comm only)
2.7(top 20%)
2-YI (no self-cite.)
5.2K
documents
150.0K
doc citations

Top Articles

#TitleJournalYearCitations
1Toxic equivalency factors (TEFs) for polycyclic aromatic hydrocarbons (PAHs)Regulatory Toxicology and Pharmacology19922,298
2Use of an aggregate exposure model to estimate consumer exposure to fragrance ingredients in personal care and cosmetic productsRegulatory Toxicology and Pharmacology20151,812
3Novel database for exposure to fragrance ingredients in cosmetics and personal care productsRegulatory Toxicology and Pharmacology20151,756
4Application of the expanded Creme RIFM consumer exposure model to fragrance ingredients in cosmetic, personal care and air care productsRegulatory Toxicology and Pharmacology20171,747
5Integrating habits and practices data for soaps, cosmetics and air care products into an existing aggregate exposure modelRegulatory Toxicology and Pharmacology20171,724
6Correlation of chemical structure with reproductive and developmental toxicity as it relates to the use of the threshold of toxicological concernRegulatory Toxicology and Pharmacology20121,549
7A strategy for structuring and reporting a read-across prediction of toxicityRegulatory Toxicology and Pharmacology20151,461
8Concordance of the Toxicity of Pharmaceuticals in Humans and in AnimalsRegulatory Toxicology and Pharmacology20001,214
9A Systematic Approach for Evaluating the Quality of Experimental Toxicological and Ecotoxicological DataRegulatory Toxicology and Pharmacology1997774
10Trace element risk assessment: essentiality vs. toxicityRegulatory Toxicology and Pharmacology2003583
11Safety Evaluation and Risk Assessment of the Herbicide Roundup and Its Active Ingredient, Glyphosate, for HumansRegulatory Toxicology and Pharmacology2000571
12Risk assessment of the mycotoxin zearalenoneRegulatory Toxicology and Pharmacology1987555
13Comparison of Cramer classification between Toxtree, the OECD QSAR Toolbox and expert judgmentRegulatory Toxicology and Pharmacology2015544
14The Dermal Sensitisation Threshold—A TTC approach for allergic contact dermatitisRegulatory Toxicology and Pharmacology2008434
15Extension of the Dermal Sensitisation Threshold (DST) approach to incorporate chemicals classified as reactiveRegulatory Toxicology and Pharmacology2015426
16Oral toxicity of silver ions, silver nanoparticles and colloidal silver – A reviewRegulatory Toxicology and Pharmacology2014418
17Refinement of the Dermal Sensitisation Threshold (DST) approach using a larger dataset and incorporating mechanistic chemistry domainsRegulatory Toxicology and Pharmacology2011413
18Reference dose (RfD): Description and use in health risk assessmentsRegulatory Toxicology and Pharmacology1988400
19The safety of chitosan as a pharmaceutical excipientRegulatory Toxicology and Pharmacology2010400
20Principles for identification of High Potency Category Chemicals for which the Dermal Sensitisation Threshold (DST) approach should not be appliedRegulatory Toxicology and Pharmacology2015394
21Health safety issues of synthetic food colorantsRegulatory Toxicology and Pharmacology2015384
22Review of health safety aspects of nanotechnologies in food productionRegulatory Toxicology and Pharmacology2009367
23Occurrences, Uses, and Properties of ChromiumRegulatory Toxicology and Pharmacology1997357
24Risk and safety assessment on the consumption of Licorice root (Glycyrrhiza sp.), its extract and powder as a food ingredient, with emphasis on the pharmacology and toxicology of glycyrrhizinRegulatory Toxicology and Pharmacology2006344
25Arsenic exposure: A public health problem leading to several cancersRegulatory Toxicology and Pharmacology2020344
26Health Implications of Nitrate and Nitrite in Drinking Water: An Update on Methemoglobinemia Occurrence and Reproductive and Developmental ToxicityRegulatory Toxicology and Pharmacology1996341
27Potency Equivalency Factors for Some Polycyclic Aromatic Hydrocarbons and Polycyclic Aromatic Hydrocarbon DerivativesRegulatory Toxicology and Pharmacology1998333
28Health benefits and potential risks related to consumption of fish or fish oilRegulatory Toxicology and Pharmacology2003333
29Chromium as an Essential Nutrient for HumansRegulatory Toxicology and Pharmacology1997330
30Ranking and prioritization of environmental risks of pharmaceuticals in surface watersRegulatory Toxicology and Pharmacology2004324
31Uniform assessment and ranking of opioid Mu receptor binding constants for selected opioid drugsRegulatory Toxicology and Pharmacology2011312
32Assessing skin sensitization hazard in mice and men using non-animal test methodsRegulatory Toxicology and Pharmacology2015311
33Human pharmaceuticals in US surface waters: A human health risk assessmentRegulatory Toxicology and Pharmacology2005310
34A rationale for determining, testing, and controlling specific impurities in pharmaceuticals that possess potential for genotoxicityRegulatory Toxicology and Pharmacology2006310
35Potential adverse effects of phthalic acid esters on human health: A review of recent studies on reproductionRegulatory Toxicology and Pharmacology2008305
36The hormesis database: The occurrence of hormetic dose responses in the toxicological literatureRegulatory Toxicology and Pharmacology2011304
37Consumer Exposure to Fragrance Ingredients: Providing Estimates for Safety EvaluationRegulatory Toxicology and Pharmacology2002295
38Bacteriophage P100 for control of Listeria monocytogenes in foods: Genome sequence, bioinformatic analyses, oral toxicity study, and applicationRegulatory Toxicology and Pharmacology2005295
39The safety of green tea and green tea extract consumption in adults – Results of a systematic reviewRegulatory Toxicology and Pharmacology2018291
40Criteria for Development of a Database for Safety Evaluation of Fragrance IngredientsRegulatory Toxicology and Pharmacology2000282
41Evaluation of the Tobacco Heating System 2.2. Part 2: Chemical composition, genotoxicity, cytotoxicity, and physical properties of the aerosolRegulatory Toxicology and Pharmacology2016278
42Safety and Advantages of Bacillus thuringiensis-Protected Plants to Control Insect PestsRegulatory Toxicology and Pharmacology2000277
43Regulatory history and experimental support of uncertainty (safety) factorsRegulatory Toxicology and Pharmacology1983269
44A Cancer Risk Assessment of Di(2-ethylhexyl)phthalate: Application of the New U.S. EPA Risk Assessment GuidelinesRegulatory Toxicology and Pharmacology1999257
45What do we (need to) know about the kinetic properties of nanoparticles in the body?Regulatory Toxicology and Pharmacology2007251
46IPCS Conceptual Framework for Evaluating a Mode of Action for Chemical CarcinogenesisRegulatory Toxicology and Pharmacology2001249
47Smoke composition and predicting relationships for international commercial cigarettes smoked with three machine-smoking conditionsRegulatory Toxicology and Pharmacology2005247
48Toxicity of silver ions, metallic silver, and silver nanoparticle materials after in vivo dermal and mucosal surface exposure: A reviewRegulatory Toxicology and Pharmacology2018246
49Applying Adverse Outcome Pathways (AOPs) to support Integrated Approaches to Testing and Assessment (IATA)Regulatory Toxicology and Pharmacology2014245
50Kinetics, safety and tolerability of (R)-3-hydroxybutyl (R)-3-hydroxybutyrate in healthy adult subjectsRegulatory Toxicology and Pharmacology2012244